Related Experiment Video

Updated: Aug 25, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

Activation of protease-activated receptor-2 leads to inhibition of osteoclast differentiation

Rosealee Smith1, Maria Ransjö, Liliana Tatarczuch

  • 1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria, Australia.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|March 26, 2004
PubMed
Abstract

Insights

Protease-activated receptor-2 (PAR-2) activation inhibits osteoclast differentiation, a key process in bone resorption. This suggests PAR-2 plays a protective role in bone by limiting excessive osteoclast formation.

Area of Science:

  • Bone Biology
  • Cell Signaling
  • Inflammation

Background:

  • Protease-activated receptor-2 (PAR-2) is expressed by osteoblasts and activated by proteases.
  • PAR-2 activation can be triggered by mast cell tryptase, factor Xa, or a specific peptide (RAP).
  • The study investigated the impact of PAR-2 activation on osteoclast differentiation.

Purpose of the Study:

  • To determine how PAR-2 activation influences osteoclast differentiation.
  • To elucidate the role of PAR-2 in bone remodeling and resorption.

Main Methods:

  • Mouse bone marrow cultures were used to assess osteoclast differentiation.
  • Osteoclast differentiation was induced by parathyroid hormone (PTH), 1,25 dihydroxyvitamin D3 [1,25(OH)2D3], and interleukin-11 (IL-11).
  • Reverse transcription-polymerase chain reaction (RT-PCR) was employed to analyze gene expression.

Main Results:

  • PAR-2 activation via RAP inhibited osteoclast differentiation induced by PTH, 1,25(OH)2D3, and IL-11.
  • RAP suppressed the expression of RANKL and the RANKL:osteoprotegerin ratio in bone and osteoblast cultures.
  • PAR-2 activation reduced prostaglandin G/H synthase-2 and IL-6 expression in response to osteogenic stimuli.

Conclusions:

  • PAR-2 activation inhibits osteoclast differentiation by modulating mediators in osteoblast lineage cells.
  • PAR-2 activation limits osteoclast differentiation, potentially protecting bone from excessive resorption.
  • PAR-2 represents a potential therapeutic target for bone-related disorders involving uncontrolled resorption.

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...